Search Results - Gowda, Ambanna

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment)

    Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes w... by Kesavadev, Jothydev, Gowda, Ambanna, Kumar, Harish, Yalamanchi, Sadasiva Rao, Lodha, Sailesh, Singh, Kiran Pal, Basu, Debasis, Asirvatham, Arthur, Shah, Navneet, Pathan, Muzammil Khan, Revanna, Manjunatha, Mukherjee, Jagat Jyoti

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    EFFECT OF REMOGLIFLOZIN ON BIOMARKERS COMPARED TO EMPAGLIFLOZIN INPATIENTS OF TYPE 2 DIABETES MELLITUS WITH CHRONIC HEART FAILURE

    EFFECT OF REMOGLIFLOZIN ON BIOMARKERS COMPARED TO EMPAGLIFLOZIN INPATIENTS OF TYPE 2 DIABETES MELLITUS WITH CHRONIC HEART FAILURE by Sengupta, Shantanu, Balagopalan, Jayagopal Pathiyil, mehta, ashwani, Suryavanshi, Satish Chainsingh, Jamwal, Naveen, Bhushan, Sumit, Gowda, Ambanna, Suryawanshi, Sachin, Gadkari, Rujuta, Barkate, Hanmant

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Are Two Gliflozins Different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin Compared With Empagliflozin on Biomarkers of Heart Failure in Indian Patients With Type 2 Diabetes Mellitus with Chronic Heart Failure (REMIT-HF Study)

    Are Two Gliflozins Different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin Compared With Empagliflozin on Biomarkers of Heart Failure in Indian Pati... by SENGUPTA, SHANTANU, PATHIYILBALAGOPALAN, JAYAGOPAL, MEHTA, ASHWANI, SAWHNEY, J.P.S., SURYAVANSHI, SATISH, JAMWAL, NAVEEN, KADAM, DILIP, GOWDA, AMBANNA, DARGAD, RAMESH, BHATE, AMIT, KAPOOR, VINOD, BHUSHAN, SUMIT, MANE, ABHISHEK, GADKARI, RUJUTA, PATIL, SAIPRASAD, BARKATE, HANMANT

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Are two Gliflozins different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin compared to Empagliflozin on Biomarkers of Heart Failure in Indian Patients of Type 2 diabetes mellitus with Chronic Heart Failure (REMIT-HF study)

    Are two Gliflozins different: A Prospective Multicenter Randomized Study to Assess Effect of Remogliflozin compared to Empagliflozin on Biomarkers of Heart Failure in Indian Patien... by Sengupta, Shantanu, Pb, Jayagopal, Mehta, Ashwani, Sawhney, Jps, Suryavanshi, Satish, Jamwal, Naveen, Kadam, Dilip, Gowda, Ambanna, Dargad, Ramesh, Bhate, Amit, Kapoor, Vinod, Bhushan, Sumit, Mane, Abhishek, Gadkari, Rujuta, Patil, Saiprasad, Barkate, Hanmant

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Studying the trend of HbA1C changes with NYHA class with SGLT2i in HFrEF T2DM Indian patients - A post-hoc analysis of REMIT-HF

    Studying the trend of HbA1C changes with NYHA class with SGLT2i in HFrEF T2DM Indian patients - A post-hoc analysis of REMIT-HF by Sengupta, Shantanu, Borulkar, Rahee, Jayagopal, P.B., Sawhney, J.P.S., Mehta, Ashwani, Suryavanshi, Satish, Jamwal, Naveen, Gowda, Ambanna, Dargad, Ramesh, Kapoor, Vinod, Bhate, Amit, Antony, Navya K., Jadhav, Mayur, Bhushan, Sumit, Choudhari, Sanjay, Patil, Saiprasad, Barkate, Hanmant

    Published in Indian heart journal
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: